SciClone Reveals FCPA-Related Legal and Compliance Spending for the Year

The California-based pharmaceutical company, under investigation since 2010, disclosed last week it had set aside $2 million for a possible FCPA settlement.

Get unlimited access to all Global Investigations Review content